Skip to main content
Top

Drugs

Issue 3/2007

Content (11 Articles)

The Role of Induction Therapy for Resectable Non-Small Cell Lung Cancer

  • Leading Article

Thomas E. Stinchcombe, Mark A. Socinski

Monoclonal Antibodies in the Treatment of Non-Hodgkin’s Lymphoma

  • Review Article

Michelle A. Fanale, Anas Younes

The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections

  • Review Article

James A. Driscoll, Steven L. Brody, Marin H. Kollef

Use of Sirolimus in Solid Organ Transplantation

  • Review Article

Joshua J. Augustine, Kenneth A. Bodziak, Donald E. Hricik

Antianginal Efficacy and Safety of Ivabradine Compared with Amlodipine in Patients with Stable Effort Angina Pectoris

  • Original Research Article

Witold Ruzyllo, Michal Tendera, Ian Ford, Kim M. Fox

Insulin Lispro

  • Adis Drug Evaluation

Dene Simpson, Paul L. McCormack, Gillian M. Keating, Katherine A. Lyseng-Williamson

Agalsidase Beta

  • Adis Drug Evaluation

Gillian M. Keating, Dene Simpson

Rupatadine

  • Adis Drug Evaluation

Susan J. Keam, Greg L. Plosker

Sorafenib

  • Adis Drug Evaluation

Kate McKeage, Antona J. Wagstaff

Sorafenib in Advanced Renal Cancer

  • Adis Drug Evaluation

Michael Staehler

Sorafenib in Advanced Renal Cancer

  • Adis Drug Evaluation

Brian I. Rini

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images